Adapt - a reminder of the potential value outside of DurAVR.

Obviously most of these products didn’t come to fruition but that was not because they didn’t work. It was due to a lack of capital, a poor business structure and a need to focus entirely on TAVR development.

However, I thought I would share this old graphic with newer investors to illustrate other products (and this is not an exhaustive list) that could be developed and sold or partnered with in the future.

This is why the value of Adapt as a platform technology needs to be considered alongside any value we ascribe to DurAVR THV and SHV when we discuss possible valuations.